Previous studies revealed a pro-oncogenic role of PIGR in hepatocellular cancer by activating Src family tyrosine kinase (Yes) and MEK/ERK signaling (Yue et al., 2017), while PIGR in breast cancer was rarely reported. Here, YES1 is linked to breast carcinoma.